Skip to Content
Discovering the causes of cancer and the means of prevention

Scientific Meetings & Events

See DCEG-sponsored events

Subscribe to DCEG Linkage Newsletter

Receive DCEG Linkage by e-mail.

Principal Investigators

Show Links to Display Other Staff Show only specific programs/branches (click + or - to show/hide)

HUMAN GENETICS PROGRAM (HGP)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

  • Achatz, Maria Isabel, M.D., Ph.D.
    Cancer genetics, inherited cancer predisposition syndromes; Clinical, Molecular and epidemiological characterization on Li-Fraumeni syndrome and Xeroderma Pigmentosum
  • Alter, Blanche P., M.D., M.P.H.
    Study of inherited bone marrow failure syndromes. Using Fanconi's anemia as the prototype for an interdisciplinary approach to elucidate the mechanisms of carcinogenesis in humans.
  • Amundadottir, Laufey, Ph.D.
    gene mapping, functional analyses, pancreatic cancer,

B

  • Brown, Kevin, Ph.D.
    Melanoma, genome-wide association studies, familial linkage studies, RNAi, cancer therapeutics.

C

  • Caporaso, Neil E., M.D.
    Molecular epidemiology of lung and other tobacco-related cancers. Family studies of lympho-proliferative cancers, i.e., chronic lymphocytic leukemia. Pharmacogenetics of genotype-phenotype relationships.

G

  • Gadalla, Shahinaz, Ph.D., M.B.Bch.
    Dr. Gadalla’s research interests focus on the role of genetic factors in cancer etiology, as well as identifying genetic and environmental risk factors among individuals at high risk of developing cancer.
  • Goldin, Lynn R., Ph.D.
    Analytic methods for detecting susceptibility genes for complex diseases by linkage and association methods. Genetic epidemiology of lymphoproliferative cancers.
  • Goldstein, Alisa M., Ph.D.
    Genetic epidemiology of cancer, integrating epidemiologic, clinical, and molecular approaches. Developing and evaluating methods to examine gene-environment interactions in complex diseases.
  • Greene, Mark H., M.D.
    Familial/hereditary cancers, genetic determinants of outcomes following cancer treatment, as well as intervention studies (cancer screening, surgical risk reduction and chemoprevention) in genetically at-risk populations, genetic modifiers of cancer risk, and leveraging alert clinical observations into novel etiologic insights.

L

  • Landi, Maria T., M.D., Ph.D.
    Association and linkage approaches in genetic epidemiology of cutaneous malignant melanoma, genetic factors of lung cancer and smoking, health consequences of dioxin exposure.

M

S

  • Savage, Sharon A., M.D.
    Genetic and molecular epidemiology of telomere biology, pediatric cancer etiology, and inherited cancer predisposition syndromes.
  • Schiffman, Mark, M.D., M.P.H.
    Molecular epidemiology to study the natural history of human papillomavirus infection on the risk of cervical cancer. Applications for cervical cancer prevention.
  • Stewart, Douglas, M.D.
    Cancer risk and phenotype in the DICER1 syndrome and neurofibromatosis type 1. Gene identification in familial tumor-predisposition disorders.

T

  • Taylor, Philip R., M.D., Sc.D
    Development of prevention strategies for cancers of the upper gastrointestinal tract (esophageal and gastric cancers) using a variety of research approaches (cancer prevention trials, early detection studies, etiologic studies, laboratory-based molecular research, and clinical nutrition studies).
  • Tucker, Margaret A., M.D.
    Studies of predictors of high cancer risk among populations with specific genetic alterations or families with high rate of cancers. Integration of clinical, epidemiologic, and molecular research.

W

  • Wentzensen, Nicolas, M.D., Ph.D.
    Etiology of cervical, ovarian, and endometrial cancer. HPV - related carcinogenesis. Discovery and translation of biomarkers for gynecological cancers. Gene methylation.

Y

  • Yang, Rose, Ph.D., M.P.H.
    Genetics of familial cutaneous malignant melanoma/dysplastic nevi syndrome and chordoma, and etiologic heterogeneity of breast cancer.